Just listened to the webinar and presentation, very impressive and already impressive data to show with a lot more to come. Valued close to nothing, what an investment opportunity. Looks like PH is advancing 3 major platforms and combining those with others. IMU's CF33, CHM's NK and RAD's isotopes could become the base for those combos, at this stage with a variety of CAR-Ts.
Bio-Tech takes time but once they got their breakthrough confirmed with trial data the sp-sky is the limit. But ASX participants rather shoot speckie miners sky high based on one drill result while they expect a bio-tech speckie to deliver 100% cure results before even having a look at them.
It is everyone's choice, I have chosen the 4 Hopper companies with IMU and CHM getting the biggest part. Investing before the herd moves in is my way, takes a lot longer than chasing a sp based on announcements every day but so far worked for me and the Stein-group (family and friends) who are all now financially secured just based on IMU alone.
And I am convinced that CHM / RAD and maybe ALA? will deliver as well.
CHM, imo a screaming buy for the patient investor.
GLTA
CHM Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)